Family spillover effects in cost-effectiveness analyses of vaccines
Approximately half of vaccine CEAs in our sample excluded family spillover effects. When included, most added family spillover costs but rarely family health effects, and generally showed more favorable results. Future vaccine CEAs should appropriately include family spillover effects to reflect vaccines' full value and support evidence-based decision-making.
Authors
- Yongsheng Qian (ORCID: https://orcid.org/0000-0002-6056-4209)
- Tara A. Lavelle (ORCID: https://orcid.org/0000-0003-1212-6973)
- Amanda L Eiden (ORCID: https://orcid.org/0000-0001-9422-1215)
- Cristina Carias
- Marie Phillips (ORCID: https://orcid.org/0009-0005-7287-4668)
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Tufts Medical Center (US)
Publication Details
- Journal
- Vaccine
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127755
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00